Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Piccini

Showing results (491-500 of 538) with videos related to

Pageof 54
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2023
Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective StudyKristen Bova Campbell, Stephanie Dougherty Eickman, Tracy Truong, et al.
American Heart Journal|December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarctionSean D Pokorney, Christina Radder, Phillip J Schulte, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2021
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg GenotypeJonathan P Piccini, Christopher Dufton, Ian A Carroll, et al.
Journal of the American College of Cardiology|December 10, 2013
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)Shaun G Goodman, Daniel M Wojdyla, Jonathan P Piccini, et al.
Journal of the American Heart Association|October 30, 2018
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AFJeffrey B Washam, DaJuanicia N Holmes, Laine E Thomas, et al.
Journal of the American Heart Association|November 26, 2020
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial FibrillationFrederik Dalgaard, Haolin Xu, Roland A Matsouaka, et al.
NEJM Evidence|May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial FibrillationSatoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
Journal of Arrhythmia|February 20, 2020
Effectiveness of catheter ablation of atrial fibrillation according to heart failure etiologyEric Black-Maier, Benjamin A Steinberg, Kevin M Trulock, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Pageof 54

Showing results (491-500 of 538) with videos related to

Sort By:
Pageof 54
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2023
Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective StudyKristen Bova Campbell, Stephanie Dougherty Eickman, Tracy Truong, et al.
American Heart Journal|December 25, 2015
High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarctionSean D Pokorney, Christina Radder, Phillip J Schulte, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2021
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg GenotypeJonathan P Piccini, Christopher Dufton, Ian A Carroll, et al.
Journal of the American College of Cardiology|December 10, 2013
Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)Shaun G Goodman, Daniel M Wojdyla, Jonathan P Piccini, et al.
Journal of the American Heart Association|October 30, 2018
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AFJeffrey B Washam, DaJuanicia N Holmes, Laine E Thomas, et al.
Journal of the American Heart Association|November 26, 2020
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial FibrillationFrederik Dalgaard, Haolin Xu, Roland A Matsouaka, et al.
NEJM Evidence|May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial FibrillationSatoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
Journal of Arrhythmia|February 20, 2020
Effectiveness of catheter ablation of atrial fibrillation according to heart failure etiologyEric Black-Maier, Benjamin A Steinberg, Kevin M Trulock, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Pageof 54